Name: Latest research reports of Biocon Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: ICICI Securities Limited

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

349.0000 1.20 (0.35%)

NSE Oct 08, 2025 15:31 PM

Volume: 3.5M

Biocon Ltd.

29 Jan 2018

349.00

0.35%

Biocon

Buy: Biocon Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Biocon reported flat YoY revenues at | 1058 crore (I-direct estimate: | 1073 crore). Biopharmaceutical segment declined 9% YoY to 369...

Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.